Clinical Trial Update: Icotinib Combined With Whole Brain Radiotherapy in Treating Multiple Brain Metastases From Non-Small Cell Lung Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating the combination of icotinib with whole-brain radiotherapy for patients with multiple brain metastases from non-small cell lung cancer…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Metastases
• Non-small Cell Lung Cancer

Drugs mentioned

• icotinib (icotinib)

Snippet

Sponsor: Zhejiang Cancer Hospital | Conditions: Lung Cancer, Metastatic Cancer | Phase 2 | Status: COMPLETED